Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase (Q80606419)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628874%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

title

Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628874%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

1 reference

Chee-Kin Hui

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628874%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Nancy Leung

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628874%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Siu-Tsan Yuen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628874%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Hai-Ying Zhang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628874%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Kar-Wai Leung

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628874%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Lei Lu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628874%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Stephen K F Cheung

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628874%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Wai-Man Wong

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628874%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

George K Lau

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628874%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Hong Kong Liver Fibrosis Study Group

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628874%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

language of work or name

English

0 references

publication date

1 August 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628874%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628874%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628874%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628874%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

395-401

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628874%20AND%20SRC:MED&resulttype=core&format=json

Hepatitis B virus infection

2 January 2020

cites work

1 reference

7 January 2021

Hepatitis B virus replication x time equals trouble

1 reference

7 January 2021

Current issues and future directions in treatment

1 reference

7 January 2021

Natural history of hepatitis B.

1 reference

7 January 2021

Natural history and prognosis of hepatitis B.

1 reference

7 January 2021

Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients

1 reference

7 January 2021

Hepatitis B e antigen and the risk of hepatocellular carcinoma

1 reference

7 January 2021

Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B

1 reference

7 January 2021

Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe

1 reference

7 January 2021

Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study

1 reference

7 January 2021

Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.

1 reference

7 January 2021

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

1 reference

7 January 2021

Predicting cirrhosis risk based on the level of circulating hepatitis B viral load

1 reference

7 January 2021

Predicting survival in hepatitis B.

1 reference

7 January 2021

A treatment algorithm for the management of chronic hepatitis B virus infection in the United States

1 reference

7 January 2021

Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005.

1 reference

7 January 2021

Natural history of patients with recurrent chronic hepatitis C virus and occult hepatitis B co-infection after liver transplantation

1 reference

7 January 2021

Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy

1 reference

7 January 2021

Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy

1 reference

7 January 2021

High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation

1 reference

7 January 2021

Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

7 January 2021

Histological grading and staging of chronic hepatitis

1 reference

7 January 2021

A comparison of fibrosis progression in chronic liver diseases

1 reference

7 January 2021

1 reference

7 January 2021

Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels

1 reference

7 January 2021

Do serum ALAT values reflect the inflammatory activity in the liver of patients with chronic viral hepatitis?

1 reference

7 January 2021

Outcomes of interferon and ribavirin treatment for chronic hepatitis C in patients with normal serum aminotransaminases

1 reference

7 January 2021

A comparison in the progression of liver fibrosis in chronic hepatitis C between persistently normal and elevated transaminase

1 reference

7 January 2021

The maze of treatments for hepatitis B

1 reference

7 January 2021

Lamivudine for patients with chronic hepatitis B and advanced liver disease

1 reference

7 January 2021

Long-term remission of chronic hepatitis B after alpha-interferon therapy

1 reference

7 January 2021

Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors

1 reference

7 January 2021

An appraisal of the histopathological assessment of liver fibrosis

1 reference

7 January 2021

Histological grading and staging in chronic hepatitis: clinical applications and problems

1 reference

7 January 2021

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

1 reference

7 January 2021

Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21724

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628874%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference